HASSANEIN WALEED H

PrivateCIK: 1430466
Location

ANDOVER, MA

HASSANEIN WALEED H (President & CEO) sold 42.2% of their position (45K shares) of TRANSMEDICS GROUP, INC. on the open market

Open‑market sale worth $7.80M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 2 sales
InsiderHASSANEIN WALEED HCIK 1430466
IssuerTRANSMEDICS GROUP, INC.CIK 1756262
DirectorOfficer· President & CEO
Since May 2019
-45K
Net shares
Net seller
$7.80M
Total sold
2
Open market trades
0B · 2S
6
Total transactions
45K acquired · 90K disposed
Non-Derivative Transactions4

Common Stock

Direct
M · Option Exercise

Shares

+20K

Price / share

$16.00

Trade value

$320K

% of position

32.4%
8/21/2024
61.64K81.64K

Common Stock

Direct
S · Sale

Shares

20K

Price / share

$171.03

Trade value

$3.42M

% of position

24.5%
8/21/2024
81.64K61.64K

Common Stock

Direct
M · Option Exercise

Shares

+25K

Price / share

$16.14

Trade value

$403.50K

% of position

40.6%
8/22/2024
61.64K86.64K

Common Stock

Direct
S · Sale

Shares

25K

Price / share

$175.00

Trade value

$4.38M

% of position

28.9%
8/22/2024
86.64K61.64K
Total

Net shares

+0.00

Net value

-$7.07M

Derivative Transactions2

Stock Option (Right to Buy)

Direct
M · Option Exercise
Converts to

Common Stock

20K shares

Shares

20K

Strike price

16.00

Held after

265.71K

Exercisable

8/21/2024

Stock Option (Right to Buy)

Direct
M · Option Exercise
Converts to

Common Stock

25K shares

Shares

25K

Strike price

16.14

Held after

153K

Exercisable

8/22/2024
Non-Derivative Holdings (Post-Transaction)1

Common Stock

Indirect
Shares owned469.36K
Total
469.36K indirect469.36K
Derivative Holdings (Post-Transaction)0
No derivative holdings reported
HASSANEIN WALEED H — Insider Transaction (Form 4) Filed Aug 23, 2024 | Finecho